Ono Pharmaceutical Co Ltd
TSE:4528

Watchlist Manager
Ono Pharmaceutical Co Ltd Logo
Ono Pharmaceutical Co Ltd
TSE:4528
Watchlist
Price: 2 120 JPY 0.93% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Ono Pharmaceutical Co Ltd?
Write Note

Ono Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ono Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Ono Pharmaceutical Co Ltd
TSE:4528
Operating Income
ÂĄ159.9B
CAGR 3-Years
18%
CAGR 5-Years
20%
CAGR 10-Years
20%
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
ÂĄ403B
CAGR 3-Years
-17%
CAGR 5-Years
13%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
ÂĄ260.5B
CAGR 3-Years
51%
CAGR 5-Years
19%
CAGR 10-Years
7%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
ÂĄ305.1B
CAGR 3-Years
14%
CAGR 5-Years
33%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
ÂĄ441.2B
CAGR 3-Years
15%
CAGR 5-Years
27%
CAGR 10-Years
17%
Astellas Pharma Inc
TSE:4503
Operating Income
ÂĄ130.6B
CAGR 3-Years
-1%
CAGR 5-Years
-13%
CAGR 10-Years
-1%

See Also

What is Ono Pharmaceutical Co Ltd's Operating Income?
Operating Income
159.9B JPY

Based on the financial report for Mar 31, 2024, Ono Pharmaceutical Co Ltd's Operating Income amounts to 159.9B JPY.

What is Ono Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
20%

Over the last year, the Operating Income growth was 7%. The average annual Operating Income growth rates for Ono Pharmaceutical Co Ltd have been 18% over the past three years , 20% over the past five years , and 20% over the past ten years .

Back to Top